Pathological outcomes of HER2-positive non-metastatic breast cancer patients treated with neoadjuvant dual anti-HER2 therapy and taxane: An Australian experience.
Asia Pac J Clin Oncol
; 16(3): 103-107, 2020 Jun.
Article
in En
| MEDLINE
| ID: mdl-31218842
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Bridged-Ring Compounds
/
Antineoplastic Combined Chemotherapy Protocols
/
Receptor, ErbB-2
/
Neoadjuvant Therapy
/
Taxoids
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Country/Region as subject:
Oceania
Language:
En
Journal:
Asia Pac J Clin Oncol
Journal subject:
NEOPLASIAS
Year:
2020
Document type:
Article
Affiliation country:
Australia
Country of publication:
Australia